Funding for this research was provided by:
National Institute of Health Research (PB-PG-1014-35007)
Received: 8 October 2019
Accepted: 20 July 2020
First Online: 8 August 2020
Ethics approval and consent to participate
: Bromley NHS Research Ethics Committee reviewed the study (reference 15/LO/1929). Participants gave written informed consent prior to the interviews and oral consent at the time.
: Consent was given for anonymous, non-identifiable quotations to be used in publications.
: Pippa Oakeshott is a member of the NIHR South London Collaboration for Leadership in Applied Health Research and Care, and of the <i>e</i>STI [CitationRef removed] consortium funded under the UKCRC Translational Infection Research Initiative which is led by Prof Sadiq. Fiona Reid is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. EA directs Aquarius Population Health that receives grants and other funding to work on projects relating to STIs from Cepheid, Binx Health, and St George’s, University of London. STS directs and EHE, EC are members of The Applied Diagnostic Research and Evaluation Unit, which has conducted diagnostic evaluations for rapid STI tests for a number of companies including: Cepheid, Binx Health, Alere, TwistDx and SpeedDx.